Partnership to develop vital long-acting antimalarials for treatment and prevention
MMV brings new partner Janssen Pharmaceuticals on board
Submit your photos and videos to help end malaria
of Artesun® (Guilin Pharma's injectable artesunate) delivered to treat children with severe malaria, saving an estimated additional 450,000 - 500,000 lives compared to quinine treatment
in clinical development prioritizing eradication and treatment for vulnerable populations including children and pregnant women
innovation award given to MMV for work on the Malaria Box
Professor Kevin Baird speaks about the challenges of delivering healthcare in Indonesia.
This infographic explains how MMV's drug discovery team works with partners to screen compounds for activity against the various stages of the parasite lifecycle.